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Abstract Therapeuticangiogenesisisapromisingstrategy
to promote the formation of new or collateral vessels for
tissue regeneration and repair. Since changes in tissue oxy-
gen concentrations are known to stimulate numerous cell
functions, these studies have focused on the oxygen micro-
environment and its role on the angiogenic potential of
endothelial cells. We analyzed the proangiogenic potential
of human endothelial colony-forming cells (hECFCs), a
highly proliferative population of circulating endothelial
progenitor cells, and compared outcomes to human dermal
microvascular cells (HMVECs) under oxygen tensions
ranging from 1% to 21% O2, representative of ischemic or
healthytissuesandstandardcultureconditions.Comparedto
HMVECs, hECFCs (1) exhibited signiﬁcantly greater pro-
liferation in both ischemic conditions and ambient air; (2)
demonstrated increased migration compared to HMVECs
when exposed to chemotactic gradients in reduced oxygen;
and (3) exhibited comparable or superior proangiogenic
potential in reduced oxygen conditions when assessed using
a vessel-forming assay. These data demonstrate that the
angiogenic potential of both endothelial populations is
inﬂuencedbythelocaloxygenmicroenvironment.However,
hECFCs exhibit a robust angiogenic potential in oxygen
conditions representative of physiologic, ischemic, or
ambient air conditions, and these ﬁndings suggest that
hECFCs may be a superior cell source for use in cell-based
approaches for the neovascularization of ischemic or engi-
neered tissues.
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Introduction
Cardiovascular diseases caused by atherosclerotic narrow-
ing or occlusion of arteries remain the leading cause of
morbidity and mortality in developed countries [1].
Although percutaneous revascularization and bypass sur-
gery provide a means to restore blood ﬂow to ischemic
tissues, not all patients with symptomatic ischemic diseases
are suitable candidates for these interventions. Therapeutic
angiogenesis is a promising treatment option for these
patients. A number of new potential therapies are under
investigation to revitalize ischemic tissues including the
delivery of recombinant angiogenic growth factors and
cytokines, the use of gene therapy to deliver plasmid DNA
encoding for proangiogenic factors, and the implantation of
proangiogenic biomaterials [2–4]. Despite promising
results, these therapies suffer from limitations including
the dependence of host cells to respond to these inductive
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presentation for efﬁcacy, and the potential inability of
donor cells to adjust to the hypoxic environment of the
damaged tissue. Cell-based approaches to therapeutic
angiogenesis may provide a viable alternative for improved
neovascularization by transplanting cells that directly par-
ticipate or indirectly promote the formation of new vessels.
Therapeutic angiogenesis may be achieved through a
cell-based approach. Compared to pharmacological strate-
gies [5, 6], the transplant of cells of the endothelial lineage
can accelerate this process by formation of new capillaries.
Local implantation of terminally differentiated endothelial
cells, both microvascular such as human dermal micro-
vascular cells (HMVECs) and umbilical vein-derived
endothelial cells (HUVECs), has yielded functional vessels
in rodent models, but these neovessels only survive for a
short period of time [7–12]. Alternatively, endothelial
progenitor cells (EPCs) represent a source of endothelial
cells that may be isolated from adult peripheral or umbil-
ical cord blood and possess high proliferative potential;
thus, eliminating the challenges in expanding autologous
HMVECs for graft endothelialization or transplantation
[13–17]. Endothelial colony-forming cells (ECFCs) repre-
sent the only EPCs that display clonal proliferative
potential, high levels of telomerase, form de novo vessels
upon implantation in vivo, and spontaneously anastomose
with the host vasculature [18]. However, the angiogenic
properties of ECFCs in ischemic or physiologic oxygen
microenvironments remain to be fully explored.
The oxygen microenvironment is a potent stimulator of
cell behavior. Oxygen tension throughout the body ranges
from nearly anoxic in cartilage and ischemic cardiac or
cerebral tissues to approximately 13% in arteries [19].
Microvascular endothelial cells from various sources
exhibit signiﬁcant differences in their proliferative,
migratory, and tubule/vessel-forming capacity as a result of
changes in environmental oxygen tension [20–22]. Endo-
thelial cells may also increase the production of proangi-
ogenic growth factors including vascular endothelial
growth factor (VEGF) and collagenases such as MMP-9 in
response to hypoxic conditions [23–25], each of which play
an important role in the process of cell-mediated vessel
formation.
We hypothesized that local oxygen tension would affect
the vessel-forming behavior of cells of the endothelial
lineage, and that endothelial cells from different sources
may exhibit different responses to hypoxic conditions. To
explore this hypothesis, we compared the proangiogenic
potential of human ECFCs (hECFCs) to HMVECs in
controlled oxygen tensions in vitro and demonstrated that
hECFCs possess comparable or enhanced proangiogenic
potential at all oxygen tensions studied when compared to
HMVECs. Thus, hECFCs are likely a superior cell source
for use in cell-based approaches focused on the neovas-
cularization of ischemic or engineered tissues.
Materials and methods
Cell culture
Human umbilical cord blood ECFCs were isolated using a
protocol approved by the Institutional Review Board of the
Indiana University School of Medicine as previously
described [18]. The adherent ECFCs were cultured in T-75
culture ﬂasks (Nunc) coated with a layer of 5 lg/cm
2 rat tail
collagen I (BD Biosciences) in EGM
-2 media supple-
mented with Lonza’s SingleQuot supplement (hydrocorti-
sone, gentamycin, human VEGF, human ﬁbroblast growth
factor(FGF),humanepidermalgrowthfactor(EGF),human
insulin-like growth factor (IGF), and heparin) and supple-
mented with 10% fetal bovine serum (FBS, JR Scientiﬁc),
1% penicillin/streptomycin, and 0.1% amphotericin b (Me-
diatech).AdultdermalHMVECswerereceivedincryogenic
ampoules (Clonetics
 HMVEC-dAd-Adult Human Dermal
Microvascular Endothelial Cells, Lonza) and cultured in
EGM
-2MV Microvascular Endothelial Cell Growth Med-
ium-2 supplemented with the Bulletkit supplement (5%
FBS, hydrocortisone, gentamycin, human VEGF, human
FGF, human EGF, human IGF, and ascorbic acid). Both
hECFCs and HMVECs were maintained in standard CO2
incubators at 37C prior to experimentation.
Controlling the oxygen microenvironment
The oxygen microenvironment was manipulated using
commercially available airtight chambers (Billups–Ro-
thenberg). A known mixture of CO2 and N2 was pumped
into the chamber and the O2 levels inside the chamber were
monitored with an oxygen sensor (Billups–Rothenberg)
attached to the outlet tube. Once the desired oxygen level
was reached, the chamber was sealed, leaving an interior
atmosphere of 5% CO2 and a precise mix of O2 and N2.A
small tray of water was placed in the hypoxia chambers to
maintain humidity after sealing. Sealed chambers were
placed in a 37C incubator during experiments. Experi-
mental endpoints, assays, and oxygen tensions employed
are described in Table 1.
Cellular proliferation
The role of the oxygen microenvironment on hECFCs and
HMVECs mitogenic potential was assessed by quantitating
cellular proliferation when cultured in varied oxygen con-
ditions ( 1% representing near anoxic conditions, 4, 8, 12,
16, and 21% O2). hECFCs and HMVECs were seeded in
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123complete media (7,500 cells/cm
2 in EGM-2MV with 5%
FBS) in 6-well culture dishes and allowed to attach over-
night. To initially determine the optimal growth substrate
for each population, hECFCs and HMVECs were seeded
on wells coated with 5 lg/cm
2 rat tail collagen or on tissue
culture plastic. Subsequent experiments were performed
with hECFCs grown on collagen and HMVECs grown on
plastic. After attachment, media was changed and plates
were placed in the desired oxygen tension for 72 h. Each
well was rinsed with Hank’s Balanced Salt Solution
(Gibco) and cells were trypsinized and scraped from the
well surfaces prior to counting. Cell counts of each well
were performed in triplicate with a Z1 Dual Coulter
Counter (Beckman).
Migration
Human endothelial colony-forming cells and HMVEC
migration at various oxygen tensions were evaluated using
a modiﬁed Boyden chamber assay as previously described
[26]. Brieﬂy, 24-well ﬂuoroblok transwells (3 lm pore
size, BD Biosciences) were coated with a thin layer of
gelatin solution (0.1% bovine skin gelatin, Sigma). Cells
(1 9 10
5 cells/well) were seeded on the top of the trans-
wells in 300 lL serum-free growth factor deﬁcient EGM-
2MV supplemented with 0.1% fatty acid-free BSA
(Sigma). Transwells were then placed over complete EGM-
2 containing 10% FBS to create a positive chemotactic
gradient, while serum-free media served as the negative
control. Plates were then placed in hypoxia chambers or
standard CO2 incubators for 24 h. Cells that migrated to the
bottom of the transwell were stained via incubation with
calcein AM (3 lg/mL in HBSS, Anaspec) for 30 min, and
ﬂuorescence was quantitated using a microplate reader
(Synergy HTTR) at 485/530 nm.
Tubule formation
The tubulogenic capacity of each cell type was determined
when cultured in varying oxygen conditions. Brieﬂy,
Matrigel (150 lL, BD Biosciences) was pipetted into 24-
well plates and allowed to gel at 37C for 1 h. Cells were
seeded on Matrigel at 2 9 10
4 cells/cm
2 in 500 lLo f
complete EGM-2MV supplemented with 5% FBS. Cells
were placed in the appropriate oxygen microenvironment
as described above, cultured for 6 h, and images of tubule
formation were captured using a Nikon Eclipse TE2000-U
and SpotRT digital camera.
Acetylated LDL uptake
Acetylated low density lipoprotein labeled with 1,10-dioc-
tadecyl-3,3,30,30-tetramethylindo-carbocyanine perchlorate
(DiI-Ac-LDL) (Biomedical Technologies) was used to
characterize ac-LDL uptake by hECFCs and HMVECs at
varying oxygen tensions. Cells were seeded in 6-well plates
at 7,500 cells/cm
2 as described above and placed in 1, 5, or
21% oxygen for 72 h. Cells were then incubated for 4 h in
complete EGM-2MV ? 5% FBS containing 10 lg/mL of
DiI-Ac-LDL at their respective oxygen tensions followed
by multiple media rinses. Images of Ac-LDL uptake were
captured by ﬂuorescence microscopy using a Nikon Eclipse
TE2000-U.
Apoptosis
The apoptotic response of hECFCs and HMVECs to differ-
ent oxygen conditions was determined by quantitating cas-
pase 3/7 activity (Caspase-Glo 3/7 Assay, Promega). Cells
were seeded (5 9 10
3 cells/well) on Nunclon Surface 96-
well white cell culture plates (Nunc) in 100 lL complete
EGM-2MV containing 5% FBS. After 24 h, nonadherent
cells were rinsed away with PBS, media was replaced, and
the 96-well plates were placed in hypoxia chambers or
standard CO2 incubators at 37C for an additional 24 h.
Plates were then equilibrated to room temperature and
100 lL of the luminescent caspase substrate/buffer mix was
added to each well. Plates were agitated at 400 rpm for 30 s
and allowed to sit for 60 min. Luminescence of each well
was quantitated using a microplate reader. Additional wells
Table 1 Experimental endpoints, assays, and oxygen tensions employed
Endpoint Assay Oxygen tension applied (%)
Cellular growth EC proliferation  1, 4, 8, 12, 16, and 21
Migration Boyden chamber assay 1, 5, and 21
Tubulogenesis Matrigel tubule formation assay 1, 5, and 21
Apoptosis Caspase 3/7 activity 1, 5, and 21
LDL uptake Acetylated LDL/ﬂuorescence 1, 5, and 21
Oxygen responsiveness Western blotting for HIF-1a 1, 5, and 21
EC endothelial cells, LDL low density lipoprotein, HIF-1a hypoxia inducible factor 1-alpha, VEGF vascular endothelial growth factor
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123ofcellswere alsoseededinordertonormalizethecaspase3/
7 quantities to cell number. 100 lL of passive lysis buffer
(Promega) was applied to each additional well at the con-
clusion of the assay and cell DNA content was determined
following the manufacturer’s instructions (Quant-iT Pico-
Green dsDNA Assay Kit, Invitrogen).
Western blot analysis
Humanendothelialcolony-formingcellsandHMVECswere
seeded on 6 well plates (5 9 10
4 cells/cm
2) and allowed to
attach overnight. The plates were then placed in hypoxia
chambers, standard cell culture incubators, or cultured in
ambient air with or without the presence of the Hypoxia
InducibleFactor1-alpha(HIF-1a)stabilizerCoCl2(100 lm,
Sigma) for 4 h, removed and rinsed with PBS, followed by
total protein collection in 4x sample buffer (20% glycerol,
4% SDS, 0.05% bromophenol blue, 160 mM Tris–HCl, and
200 mM DTT). Protein concentration was determined using
the Amido Black method, a solid-phase method for the
quantitation of protein in the presence of sodium dodecyl
sulfate and other interfering substances [27]. 20–40 lgo f
protein per sample were resolved in 4–20% Tris–HCl
acrylamide gels and transferred onto 0.2 mm nitrocellulose.
Blots were blocked in 0.5% nonfat milk in Tris-buffered
salinewith0.05%Tween-20(TBST)for2 handprobedwith
rabbit anti-human polyclonal antibody to HIF-1a (1:400 in
blocking buffer; Cayman Chemical, 10006421) overnight
at 4C. Membranes were washed and probed with horse-
radish peroxidase-conjugated secondary antibodies at
1:2,500 (Cayman) and reactive bands were visualized using
enhanced chemiluminescence and X-ray ﬁlm. Membranes
werethenstrippedandblockedasecondtimewith5%nonfat
milk in TBST for 1 h and probed with a-tubulin (11H10)
Rabbit monoclonal antibody (1:1,000 in blocking buffer;
Cell Signaling, 2125S) overnight at 4C. Secondary anti-
bodies and visualization were carried out as previously
stated.
Statistical analysis
The values on the graphs represent means and standard
error unless otherwise stated. Statistical analysis was per-
formed using a paired Student’s t-test. P values less than
0.05 were considered statistically signiﬁcant.
Results
Cellular proliferation
We initially examined the proliferative capacity of hECFCs
and HMVECs in ambient air both in the presence and
absence of rat tail collagen I on the culture plates, as pre-
vious reports described ECFC culture on this extracellular
matrix protein [28]. hECFC proliferation was signiﬁcantly
increased by the presence of the collagen substrate, while
HMVEC proliferation was signiﬁcantly decreased
(Fig. 1a). Therefore, we elected to culture each cell pop-
ulation on the surface that promoted optimal proliferation
for each respective cell type for the remainder of the
studies.
Compared to HMVECs, hECFCs exhibited increased
proliferation at both low ( 1%, 4%) and high oxygen
tensions (16, 21%) (Fig. 1b). No signiﬁcant differences in
proliferation were noted between hECFCs and HMVECs at
mid-range oxygen levels (8, 12%). hECFCs appeared to
Fig. 1 a hECFC and HMVEC proliferation on collagen I. *P\0.05
versus same cell type cultured in the absence of collagen. Data are
mean ± SE (n = 3). b Proliferation of hECFCs and HMVECs at
varying oxygen tensions. *P\0.001 versus HMVECs at correspond-
ing oxygen tension. Data are mean ± SE (n = 6)
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123show a proliferation plateau at mid to high oxygen ten-
sions, while HMVECs peaked at mid-range oxygen ten-
sions and returned to a lower proliferative capacity at
higher oxygen tensions. Doubling times were calculated for
both cell types at each oxygen tension using the following
equation: N ¼ N0   expðkp   tÞ, where N represents the
ﬁnal cell number, N0 is the initial cell number, kp is the
proliferation rate constant, and t represents the culture time
(Table 2). The greatest differences in cell proliferation
doubling times were observed between hECFCs and
HMVECs at  1% O2 (3.12 versus 9.00 days, respectively)
and 21% O2 (1.56 versus 3.58 days, respectively).
Cell migration
Cell migration assays performed at three distinct oxygen
tensions (1, 5, and 21% O2) revealed a statistically sig-
niﬁcant increase in the chemotactic response of hECFCs
versus HMVECs in each condition (Fig. 2). Compared to
no gradient at 1, 5, or 21% O2, hECFC migration increased
9.69-, 7.86-, and 19.67-fold, while HMVEC migration
increased 3.56-, 4.35-, and 5.68-fold (P\0.05 for each
oxygen tension). Cell migration was visibly conﬁrmed by
imaging the bottom of transwells stained with calcein using
inverted ﬂuorescence microscopy (Fig. 3). A comparison
of calcein uptake and ﬂuorescence from an identical
number of hECFCs and HMVECs revealed no signiﬁcant
differences (data not shown).
Tubule formation
Morphological differences were clearly observed for
tubules generated by both hECFCs and HMVECs at dif-
fering oxygen tensions. Speciﬁcally, both hECFCs and
HMVECs cultured in 1 and 5% O2 produced well-rounded,
circular tubules with borders typically comprised of more
than one cell (Fig. 4a, b, d, e). Tubules formed at 21% O2
by both cell populations were more polygonal in shape, less
likely to be fully enclosed, and typically bordered by a
layer of only one cell (Fig. 4c, f). Regardless of cell type,
individual cell morphology appeared to adjust to the oxy-
gen tension, with cells in reduced oxygen environments
maintaining their cobblestone-like appearance, and those in
higher oxygen conditions exhibiting an elongated mor-
phology. Compared to hECFCs, HMVECs were less likely
to adhere and remain viable at each oxygen tension when
seeded on Matrigel as demonstrated by numerous ﬂoating
cells (Fig. 4d–f).
Apoptosis
We detected differences in markers of programmed cell
death between HMVECs and hECFCs cultured at 1, 5, or
21% oxygen over 24 h. hECFCs expressed signiﬁcantly
higher caspase activity than HMVECs when cultured at
21% O2 (Fig. 5). In addition, both hECFCs and HMVECs
exhibited signiﬁcant increases in caspase activity when
cultured at 1% O2 compared to 5% and 21% O2, and these
levels were statistically similar. Markers of apoptosis were
statistically similar for each individual cell type when
cultured in 5% O2 and ambient air.
Acetylated LDL uptake
The ability to engulf acetylated LDL is a characteristic trait
of cells of the endothelial phenotype, and this property is
commonly used to isolate and identify endothelial cells
from other cell types and monitor cellular metabolism [29].
Acetylated LDL incorporation assays performed at three
distinct oxygen tensions (1, 5, and 21% O2) revealed no
qualitative differences between hECFCs and HMVECs
(Fig. 6). Upon quantitating the number of cells per ﬁeld of
view with internalized ﬂuorescence, we observed that all
Table 2 Population doubling times of hECFC and HMVEC cultured
in varied oxygen tensions
Oxygen
tension (%)
hECFC
doubling
time (days)
HMVEC
doubling
time (days)
 1 3.12 ± 0.15* 9.00 ± 0.81
4 1.85 ± 0.03* 2.40 ± 0.07
8 1.54 ± 0.02 1.57 ± 0.08
12 1.51 ± 0.03 1.40 ± 0.04
16 1.40 ± 0.04* 2.15 ± 0.02
21 1.56 ± 0.03* 3.58 ± 0.31
* P\0.05 versus HMVECs at same O2 tension
Fig. 2 Fold increase in cell migration when exposed to a chemotactic
gradient at varying oxygen tensions. Data are mean ± SE (n = 4).
*P\0.05 versus HMVECs at same O2 tension
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acetylated LDL.
hECFCs respond to changes in oxygen tension
Both hECFCs and HMVECs expressed high levels of HIF-
1a when cultured at 1% O2 similar to cells cultured in the
presence of CoCl2 (Fig. 7). However, cells cultured at 5 or
21% O2 revealed little to no HIF-1a present in the cell
lysates after 4 h, suggesting that physiological oxygen
levels are insufﬁcient to induce HIF production. Similar
results were observed with both cell types after 18 h (data
not shown).
Fig. 3 Fluorescence
microscopy images of transwell
undersides reveal calcein-
stained hECFCs (a, b) and
HMVECs (c, d) that crossed the
barrier with (a, c) or without (b,
d) a chemotactic gradient in 1%
oxygen. Images are
representative of four
independent experiments. Scale
bars represent 200 lm
Fig. 4 Tubulogenesis with
hECFCs (a–c) and HMVECs
(d–f) cultured at 1, 5, or 21%
oxygen. Images are
representative of four
independent experiments. Scale
bars represent 200 lm
Fig. 5 Apoptotic response of hECFCs and HMVECs under varying
oxygen tensions. *P\0.05 versus same cell type at 5 or 21% O2. Data
are mean ± SE (n = 4). **P\0.05 versus HMVECs at 21% O2
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Human endothelial colony-forming cells and HMVECs
were studied using in vitro angiogenesis assays under
varying oxygen tensions to test our hypothesis that hypoxic
conditions could alter the proangiogenic potential of these
cells. hECFCs performed as well or better than HMVECs
when characterizing their proangiogenic potential, with
particular emphasis on proliferation, migration, and tubu-
logenesis. These ﬁndings indicate that endothelial cell
populations respond differently to hypoxic conditions and
suggest that hECFCs may be a superior population for the
neovascularization of ischemic or engineered tissues.
Endothelial colony-forming cells represent a highly
proliferative population of circulating endothelial cells that
have recently been distinguished from other EPC popula-
tions by their lack of hematopoietic surface markers and
their ability to promote vasculogenesis [18, 30, 31]. Much
like other progenitor cell populations, the number and
function of circulating ECFCs diminishes with age and
deteriorating health but increases after acute myocardial
infarction. These data suggest a possible link between the
presence of these cells in the circulation, cardiovascular
health, and ongoing repair [32, 33]. Compared to termi-
nally differentiated endothelial cells, the ability to isolate
these cells noninvasively from cord blood provides a dis-
tinct advantage over skin biopsy.
Weobservedastrongcorrelationbetweenoxygentension
and three hallmarks of angiogenesis: cell proliferation,
migration, and tubule formation. hECFCs exhibited a sig-
niﬁcantly greater proliferative capacity compared to
HMVECsatlowoxygentensionsinvitro( 1%and4%O2),
simulating conditions found within hypoxic tissues in vivo.
The increased proliferative potential observed with hECFCs
under hypoxic conditions suggests the potential for accel-
erating vessel formation. Furthermore, these data suggest
that fewer cells would be required for transplant in the
clinical setting to form functional vessels compared to
existing methods using HMVECs. Our results also conﬁrm
the increased proliferative capacity of hECFCs compared to
HMVECs in ambient oxygen typically associated with cell
culture (21% O2). This proliferative ability effectively
reduces the time required to achieve sufﬁcient cell numbers
for transplantation to treat ischemic tissues or incorporate
withinatissue-engineeredscaffold.Finally,theproliferative
capacity of hECFCs over a wide range of oxygen tensions
differed from that of HMVECs. HMVEC proliferation
peaked near physiological oxygen tensions observed in the
arterial system [19]. In contrast, hECFC proliferation
plateaued at 8% O2 and remained constant at the higher
levels assessed. These data suggest that changes in the
oxygen microenvironment may have less of an effect on the
proliferative capacity of hECFCs compared to HMVECs.
Human endothelial colony-forming cells also appeared
to possess a higher level of sensitivity to a chemotactic
gradient compared to HMVECs when quantitating cell
migration at reduced oxygen tensions (1 and 5% O2).
Measurements of ﬂuorescence intensity revealed increased
hECFC migration compared to HMVECs in the presence of
a chemotactic gradient. These data suggest that hECFCs
Fig. 6 Acetylated LDL uptake
by hECFCs (a–c) and HMVECs
(d–f) at 1, 5, and 21% oxygen.
Images are representative of ﬁve
independent experiments. Scale
bars represent 200 lm
    1%        5%      21%   CoCl2           1%      5%      21%  CoCl2
HIF-1α
α-tub
ECFCs             HMVECs 
Fig. 7 Expression of HIF-1a in hECFCs and HMVECs under varying
oxygen tensions after 4 h. Bands represent protein expression at 1, 5,
and 21% oxygen, or in the presence of CoCl2 (left to right). Lower
band represents a-tubulin expression
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stimuli in vivo when compared to HMVECs. Further, the
reduced migration observed with hECFCs in the absence of
a cytokine gradient suggests that hECFCs may remain at
the transplant site to participate in capillary formation and
avoid migration away from the desired tissue.
Regardless of oxygen tension, we observed robust
tubule formation and uptake of acetylated LDL for both
hECFCs and HMVECs. Both cell populations formed
capillary-like structures at all oxygen levels tested. How-
ever, we detected distinct differences in tubule morphology
between cell types at the same oxygen tension, with
hECFCs forming smooth and more well-rounded tubules
compared to HMVECs. Similar to reports by others, cell
aggregation limited the accuracy of quantitation of cells
participating in tubular structures [34]. Although it is
widely accepted that tubulogenesis and LDL uptake are
insufﬁcient to characterize the endothelial lineage of dif-
ferent progenitor cell populations [30], these assays aid in
assessing the capacity of an endothelial cell to maintain a
functional phenotype when exposed to harmful environ-
mental stimuli such as hypoxia. We have shown that
hECFCs cultured in oxygen tensions representative of
ischemia exhibit characteristic behavior similar to mature
microvascular cells residing within a hypoxic environment.
Our ﬁndings suggest that hECFCs are less sensitive to
apoptotic stimuli than HMVECs. While an approximately
3.5-fold increase in HMVEC caspase activity was observed
at 1% O2 compared to ambient conditions, hECFC caspase
activity increased by only approximately twofold. While
hECFCs did express higher baseline caspase levels than
HMVECs when cultured under ambient conditions, both
cell types expressed nearly identical caspase concentrations
under conditions approximating those within hypoxic tis-
sue. These data suggest that both cell types may have
similar survivability when transplanted into ischemic sites
in vivo. These data are in agreement with prior studies by
Ingram et al. [35] that reported increased ECFC apoptosis
upon the introduction of peroxide-mediated oxidative
stress and simulation of vascular injury. It is likely that the
culture of cells in reduced oxygen may initiate oxygen-
responsive cues similar to those stimulated by small mol-
ecules, and the presence or magnitude of these cues
directly impact apoptosis.
In order to probe the mechanism for differences in pro-
angiogenic potential, we investigated the upregulation of
HIF-1a by each cell type in response to oxygen tension. Our
datarevealedastarkupregulationofthispotenttranscription
factor in reduced oxygen (1% O2) for both cells, while little
to no expression was observed at higher oxygen tensions.
These results differ from earlier studies that reported only
minor shifts in HIF-1aexpression across conditions in EPCs
cultured under similar oxygen levels [36]. HIF-1a
upregulation signals the increase in transcription of growth
factors such as VEGF that may, in turn, enhance endothelial
cell proliferation and migration. However, we failed to
detect signiﬁcant increases in VEGF secretion by hECFCs
comparedtoHMVECs in1,5,or21%O2usingELISA(data
not shown). The transplant of EPCs genetically engineered
to overexpress HIF-1a has demonstrated increased prolif-
eration, migration, and capacity to promote reperfusion in
vivo [37]. Our observation of comparable HIF upregulation
and VEGF secretion in both cell types stimulated by local
oxygen conditions excludes the contribution of endogenous
proangiogenic molecules as the sole mechanism for the
increased proliferative capacity observed with hECFCs.
Additional studies that focus on the molecular differences in
cell division are warranted to explain these ﬁndings.
Conclusions
These data demonstrate that the proangiogenic response of
cells of the endothelial lineage is highly dependent upon
local oxygen tension and may differ in response to varying
oxygen levels. Further investigation of the mechanism(s)
responsible for these ﬁndings may reveal the optimal
endothelial cell populations and conditions for the neo-
vascularization of ischemic sites.
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